Cancer Vaccines
Findings in cancer vaccines reported from P. Sabbatini and co-researchers
Published in OBGYN and Reproduction Week, February 15th, 2010
In this recent study, researchers in the United States conducted a study "To describe the characteristics of a series of study populations of ovarian cancer patients with identical eligibility criteria in second or subsequent clinical remission (cCR) and to propose endpoint benchmarks for future consolidation studies. The patient populations consisted of those (1) untreated (U; observed until progression: n = 35, (2) receiving imatinib (G; n=32), (3) receiving goserelin and bicalutamide (A; n = 32), and (4) receiving vaccine (V; n = 68; total = 167)."
"The endpoint of the combined analysis was progression-free Survival in second remission (PFS 2). characteristics were...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of OBGYN and Reproduction Week
More Articles from OBGYN and Reproduction Week
- Columbia University's Mailman School of Public Health
Use of acetaminophen in pregnancy associated with increased asthma symptoms in children - Journal of the National Cancer Institute
News brief: Contrast agent with MRI improves detection of lymph nodes metastases - Journal of the National Cancer Institute
Symptoms have little value for early detection of ovarian cancer - Breast Cancer
Investigators at University of Marburg publish new data on breast cancer - Breast Cancer
Recent findings in breast cancer described by researchers from Copenhagen University - Carcinoma
Data on carcinoma reported by researchers at University of Maryland, Medical Department - More from this issue of OBGYN and Reproduction Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
